A group that has been fighting to improve access to opioid agonist therapy for decades has filed a complaint with the B.C.

Study represents the first clinical application of CMND-100, the Company’s proprietary drug platform Vancouver, Canada, March 18, 2025 (GLOBE ...

New guidelines around involuntary care are receiving criticism from those who advocate for drug users and their families ...

A Washington, D.C., district court judge ruled on March 7 that Harry's U.S. immigration files be released by the end of day ...

British Columbia clinicians have received new guidance about involuntary care for people who use drugs, which includes ...

Conservative Surrey-Cloverdale MLA Elenore Sturko says the changes do not deal with underlying addiction issues ...

Study represents the first clinical application of CMND-100, the Company's proprietary drug platform Vancouver, Canada, March 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: ...

The guidance from Dr. Daniel Vigo, B.C.'s first chief scientific adviser for psychiatry, is aimed at helping clinicians and others decide when involuntary admission is appropriate for people with both ...

VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...

Kevin Brosseau is seeking to stem the flow of a deadly opioid not only to reverse U.S. tariffs but to end domestic drug deaths.